Clinical Trials Directory

Trials / Completed

CompletedNCT01145235

Swedish Macrolane Registry

Status
Completed
Phase
Study type
Observational
Enrollment
1,300 (actual)
Sponsor
Galderma R&D · Industry
Sex
Female
Age
Healthy volunteers
Accepted

Summary

A Registry to monitor long term safety in female subjects after treatment with Macrolane VRF20 and/or MacrolaneT VRF30 in the breasts.

Conditions

Timeline

Start date
2010-04-01
Primary completion
2019-01-01
Completion
2019-01-01
First posted
2010-06-16
Last updated
2022-08-25

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01145235. Inclusion in this directory is not an endorsement.